Browse the full directors' dealings record of 에스바이오메딕스, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Market capitalisation: €453.3bn. The latest transaction was disclosed on 22 April 2026 — Purchase. Among the most active insiders: 타이거자산운용투자일임. The full history is accessible without an account.